首页> 外国专利> NOVEL PHENANTHRENE-RUTHENIUM COMPOUND AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING SAME AS EFFECTIVE COMPONENT

NOVEL PHENANTHRENE-RUTHENIUM COMPOUND AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING SAME AS EFFECTIVE COMPONENT

机译:预防或治疗有效成分相同的新型菲-钌化合物和药物组合物

摘要

The present invention relates to a novel phenanthrene-ruthenium compound and a pharmaceutical composition for preventing or treating cancer comprising the same as an effective component. The phenanthrene-ruthenium compound inhibits Akt-mTOR signal paths in cancer cells, increases caspase activity, activates autodigestion of cancer cells, and induces apoptosis, thereby showing excellent anti-cancer activity of inhibiting proliferation of cancer cells. Also, the phenanthrene-ruthenium compound shows excellent anti-cancer activity at low concentration than an existing anti-cancer agent, thereby being used for preventing or treating cancer.;COPYRIGHT KIPO 2017
机译:本发明涉及新颖的菲钌化合物和用于预防或治疗癌症的药物组合物,所述化合物作为有效成分。菲钌化合物抑制癌细胞中的Akt-mTOR信号路径,增加胱天蛋白酶活性,激活癌细胞的自消化作用,并诱导凋亡,从而显示出优异的抗癌活性,可抑制癌细胞的增殖。同样,菲钌化合物在低浓度下也比现有的抗癌剂显示出优异的抗癌活性,从而可用于预防或治疗癌症。; COPYRIGHT KIPO 2017

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号